As of August 2025, WST's current EPS stands at $6.72, according to the latest financial reports. West Pharmaceutical Services's EPS for 2024 amounted to $6.75, marking a drop from $7.98 in 2023. WST reported an EPS of $1.82 for the quarterly report ending on Jun 30, 2025.
For 2024, West Pharmaceutical Services's EPS was $6.75, a drop of 15.4% from $7.98 in 2023. The quarterly per-share earnings for the period ending Jun 30, 2025, was $1.82, indicating a 19.7% increase from the same quarter last year. WST's 12-month EPS stands at $6.72 as of June 2025. West Pharmaceutical Services's annual EPS in 2023 stood at $7.98, a 1.4% increase year-over-year.
West Pharmaceutical Services has registered an increase in EPS of 19.7% during the last 12 months (YoY, quarterly). In the last three years, WST recorded an average annual EPS growth rate of -8.8%. West Pharmaceutical Services had an average annual EPS growth rate of 15.6% during the last 5 years. Across the last decade, WST had an average annual EPS growth of 14.2%.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
JNJ Johnson & Johnson | 18.42 | -57.9% | -9.7% | 0.4% |
MDT Medtronic plc | 25.59 | 31% | -1.1% | 0.3% |
TFX Teleflex Inc | 27.35 | -80.3% | -47.6% | -31.7% |
BDX Becton Dickinson & Co | 35.18 | 18.3% | -5.3% | 8% |
WST West Pharmaceutical Services Inc | 35.86 | -15.4% | -8.8% | 15.6% |
SYK Stryker Corp | 49.36 | -5.8% | 14.1% | 7.1% |
ICUI Icu Medical Inc | N/A | -292.7% | N/A | N/A |
BAX Baxter International Inc | N/A | -124.2% | N/A | N/A |
PLL Piedmont Lithium Inc | N/A | -189.5% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.